Mitsubishi UFJ Asset Management
IMMU

Mitsubishi UFJ Asset Management’s Immunomedics Inc IMMU Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-4,245
Closed -$361K – 1043
2020
Q3 		$361K Buy
4,245
+139
+3% +$7.03K ﹤0.01% 817
2020
Q2 		$146K Sell
4,106
-3,020
-42% -$88.3K ﹤0.01% 925
2020
Q1 		$96K Buy
7,126
+1,600
+29% +$26.9K ﹤0.01% 932
2019
Q4 		$109K Sell
5,526
-1,337
-19% -$23.6K ﹤0.01% 947
2019
Q3 		$91K Buy
6,863
+1,144
+20% +$16.8K ﹤0.01% 913
2019
Q2 		$79K Sell
5,719
-365
-6% -$5.49K ﹤0.01% 934
2019
Q1 		$117K Buy
6,084
+706
+13% +$11.4K ﹤0.01% 865
2018
Q4 		$80K Sell
5,378
-364
-6% -$7.23K ﹤0.01% 874
2018
Q3 		$120K Buy
+5,742
New +$136K ﹤0.01% 834

Mitsubishi UFJ Asset Management's IMMU Position: Q4 2020 in Review

Mitsubishi UFJ Asset Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 4,245 shares — an estimated $361K sold.

Mitsubishi UFJ Asset Management first reported a position in IMMU in Q3 2018 and held it in 9 quarters. The position peaked at $361K in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Mitsubishi UFJ Asset Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Mitsubishi UFJ Asset Management sold 4,245 Immunomedics Inc shares in Q4 2020, an estimated $361K.
  • Mitsubishi UFJ Asset Management first reported a position in Immunomedics Inc in Q3 2018 and held it in 9 quarters.
  • Mitsubishi UFJ Asset Management's Immunomedics Inc position peaked at $361K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q4 2020, filed 9 Feb 2021.